본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

목차보기

Title page 1

Contents 4

Acknowledgements 5

Abbreviations 6

1. Introduction 7

1.1. Scope of the guidance document 7

1.2. Objectives 7

1.3. Target audience 7

1.4. Approach to development of this guidance 7

1.5. Declarations of interest 8

2. Taenia solium taeniasis and cysticercosis 9

2.1/2.2. Geographical distribution 10

2.2/2.3. Case definitions 11

2.2.1/2.3.1. T. solium taeniasis 11

2.2.2/2.3.2. Neurocysticercosis 11

2.3/2.4. Diagnosis 12

2.4/2.5. Treatment 12

2.5/2.6. Prevention and control 13

3. About T. solium taeniasis and cysticercosis data 14

3.1. Use of health facility data on T. solium taeniasis and cysticercosis 14

3.2. Data collection and reporting 14

4. T. solium taeniasis and cysticercosis indicators: rationale 16

5. Data collection and analysis 18

5.1. Parameters and analyses 18

5.2. Data interpretations and triggered actions 19

6. Conclusion 21

References 22

Tables 14

Table 1. Benchmarks for tracking programme progress towards 2030 road map targets 14

Table 2. Recommended minimum core indicators, definitions and disaggregation 16

Table 3. Health-facility level data collection and reporting 19

Figures 9

Fig. 1. Life cycle of the T. solium parasite 9

Fig. 2. Symptoms and signs compatible or associated with neurocysticercosis 10

Fig. 3. Geographical distribution of T. solium endemicity 11

Fig. 4. Key indicators for global reporting on T. solium by Member States 14